Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > You Probably Missed The Train Under 10 Cents

<< Previous

Bullboard Posts

Next >>

Comment by viktorskateon Jun 19, 2018 9:54pm

60 Views

Post# 28196031

RE:You Probably Missed The Train Under 10 Cents

I am with you Hoto, I am expecting this to open at around a dime, even if it opens at 0.09 or 0.095, we will definietly run north of dime, could potentially hit 0.20 !! By mid August , we should be at around 0.50 !! And yeah, if we do get news tomorrow, we will for sure open north of a dime !!

<< Previous

Bullboard Posts

Next >>

How Canadian investors can benefit from flow-through shares